UK Life Sciences Company Directory

Precision oncology biotech targeting novel DNA damage response pathways

Nodus Oncology is a preclinical-stage biotechnology company developing small molecule inhibitors against novel DNA damage response targets for molecularly defined cancer patient populations. The company's pipeline is focused on synthetic lethality and collateral vulnerabilities in tumours with specific DNA repair…

Clinical-stage developer of oncolytic immunotherapies for cancer treatment

Replimune is the UK research and development site of Replimune Group, a clinical-stage biotechnology company developing oncolytic immunotherapies for cancer. Its platform uses genetically engineered herpes simplex viruses to selectively replicate within and destroy tumour cells, releasing tumour antigens and…

Preclinical DMPK, bioanalysis and toxicology CRO

Pharmidex is a UK contract research organisation providing preclinical drug discovery and development services across DMPK, bioanalysis, toxicology, histology and in vitro ADME. Operating under GLP and GCP accreditation from its Hatfield facility, the company supports programmes in oncology, CNS, respiratory and…

Novel antibiotic-sparing therapeutics for chronic wound care

ONYA Therapeutics is a biotechnology company developing novel pharmaceutical treatments for acute and chronic wounds. The company's pipeline centres on a patented controlled-release drug delivery technology designed to manage wound exudate and reduce reliance on antibiotics, addressing antimicrobial resistance in…

Polymer-based rapid diagnostic technology for bacterial and fungal infections

Molecular Titans is a University of Bradford spin-out developing a patented polymer nanotechnology platform for rapid infection diagnosis. Its thermoresponsive polymers bind selectively to bacterial and fungal pathogens, producing a measurable signal within minutes rather than days. Initial applications include…

Multi-disciplinary science and innovation campus with a major life sciences cluster

Harwell Science and Innovation Campus is a 700-acre science and technology campus in Oxfordshire, founded in 1946 and home to over 200 organisations. Managed by a joint venture of the Science and Technology Facilities Council, UK Atomic Energy Authority, and Brookfield, the campus hosts three thematic clusters in…

Microbial and enzyme products for environmental biotechnology applications

Biological Preparations is a UK developer and manufacturer of bio-based products using microbial, enzyme, and plant extract technology. Its formulations address cleaning, disinfection, odour control, grease management, and wastewater treatment across industrial, agricultural, marine, and commercial sectors. The…

AI-powered dental X-ray diagnostic software

BeCertain develops AI-powered software for interpreting dental X-rays. Its machine learning models are trained on annotated radiograph datasets to help clinicians detect caries, periodontal disease and other oral abnormalities. The company is a joint spinout from King's College London and the University of Surrey, and…

Generic injectable medicines for NHS secondary care

Bowmed Ibisqus is a privately owned pharmaceutical company supplying generic injectable medicines to NHS hospitals and the private healthcare sector. Operating as a marketing authorisation holder and distributor, the company specialises in injectable antibacterials spanning penicillin, cephalosporin, macrolide, and…

Cell-free enzymatic DNA manufacturing for genetic medicines

Touchlight is a contract development and manufacturing organisation producing synthetic DNA for genetic medicine applications using a cell-free enzymatic process. Its linear, covalently closed DNA constructs are free from bacterial sequences and antibiotic resistance genes, offering regulatory and safety advantages…

AI-designed enzymes for enzymatic recycling of plastics and textiles

Epoch Biodesign is a London-based industrial biotech developing AI-engineered enzymes for the biorecycling of mixed plastics and textiles. The company's platform uses machine learning to design enzymes that deconstruct waste materials at the molecular level, recovering high-purity chemical building blocks for…

AI platform generating novel therapeutic proteins for biotech partners

Latent Labs is a UK-based developer of artificial intelligence models that generate entirely new therapeutic proteins not found in nature. Building on foundational AI protein-structure research, the company's platform designs proteins tailored to specific biological functions, aiming to expand the range of diseases…

Fermentation-derived food ingredients from agricultural waste streams

Fermtech is a biotechnology company that applies solid-state fungal fermentation to upcycle agricultural and brewing waste streams into food ingredients. Its lead product is produced from cocoa shells using Aspergillus oryzae fermentation and functions as a lower-cost, lower-carbon cocoa-enhancing ingredient for…

Microfluidic instruments for protein interaction and single-cell analysis

Fluidic Sciences is a company developing and supplying instruments for biopharmaceutical research, combining two complementary technology platforms. Its core offering covers in-solution protein interaction characterisation without immobilisation, alongside a high-throughput picodroplet platform for single-cell…

Spider-inspired protein fibre spinning for sustainable and biocompatible materials

Spintex Engineering is a developer of bioinspired silk fibres, produced from a liquid protein feedstock using a spider-inspired self-assembly process. The technology requires no hazardous chemicals, with water as the only by-product, and is significantly more energy efficient than synthetic fibre production. Spintex's…

Data-driven cis-bispecific antibody-drug conjugates for solid tumour cancers

Promatix Biosciences is an oncology drug discovery company developing next-generation bispecific antibody-drug conjugates through data-driven target pairing. Using a proteomics database and computational algorithms, the company identifies antigen combinations enabling selective tumour targeting, aiming to reduce…

Combinatorial stem cell screening platform for therapy development

Plasticell is a biotechnology company developing cell and gene therapies and enabling drug discovery through its proprietary platform. The technology uses bead-based combinatorial screening to test thousands of cell culture variable combinations in parallel, identifying optimised protocols for stem cell expansion,…

Bioinformatics CRO delivering omics data analysis and interpretation

Fios Genomics is an Edinburgh-based bioinformatics contract research organisation providing data analysis and interpretation services across genomics, transcriptomics, proteomics and metabolomics. Serving pharmaceutical, biotechnology, and academic clients globally, the company specialises in translating complex omics…

Patient-derived mitochondrial screening for preclinical drug discovery

Mitotype Precision Labs is a contract research organisation providing patient-derived cellular assays for drug discovery and preclinical evaluation. Its screening services use fibroblasts, neurons and astrocytes to measure mitochondrial function, lysosomal biology and other disease-relevant cellular responses. The…

Targeted radiotheranostics for treatment-resistant solid tumours

Nuclide Therapeutics is a King's College London spin-out developing targeted radiopharmaceuticals for treatment-resistant solid tumours. Its radiotheranostic approach uses tumour-binding molecules labelled with diagnostic or therapeutic radionuclides to identify and attack cancer cells. Lead programmes target ALDH1A1…